Black Patients Face Significant Underdiagnosis of Long COVID, Study Finds

A new report published in Health Affairs highlights a persistent disparity in post-pandemic healthcare, revealing that Black patients in the United States are being diagnosed with long COVID at significantly lower rates than white patients. Despite evidence that Black communities experienced disproportionate rates of acute COVID-19 infection, hospitalization, and death, the diagnostic gap suggests that many Black individuals experiencing lingering, debilitating symptoms are not receiving formal clinical recognition or specialized care.

Long COVID—a complex condition characterized by persistent fatigue, brain fog, respiratory issues, and cardiovascular complications—often requires comprehensive diagnostic evaluation. However, structural inequities within the healthcare system, including unequal access to specialized long COVID clinics and implicit bias during clinical assessments, continue to prevent Black patients from obtaining an accurate diagnosis. When symptoms are dismissed or misattributed, patients are left without access to emerging treatments, formal workplace accommodations, and necessary disability support.

Addressing Barriers to Diagnostic Equity

The underdiagnosis of long COVID among Black Americans reflects broader, long-standing systemic challenges in medical care. Early in the pandemic, Black communities faced elevated exposure risks and severe outcomes due to environmental factors, occupational risks, and unequal health resource allocation. The current findings indicate that these inequities extend into the chronic phase of the disease, where subjective symptoms like chronic pain and cognitive fatigue are frequently minimized by clinicians.

To close this gap, health experts emphasize the need for standardized diagnostic protocols that account for social determinants of health and community-based outreach. Ensuring that primary care providers in safety-net hospitals and community health centers have the tools and training to screen for post-acute sequelae of SARS-CoV-2 (PASC) is critical to identifying affected individuals early and connecting them with multidisciplinary care networks.

The Critical Role of Diverse Clinical Workforces

The persistent underdiagnosis of post-viral conditions in Black populations underscores the urgent imperative to build a more diverse and culturally competent healthcare workforce. Historically Black Colleges and Universities (HBCUs) remain foundational to this effort, training a substantial proportion of the nation's Black physicians, nurses, public health professionals, and clinical researchers.

Clinicians trained at HBCUs are uniquely positioned to recognize and address health disparities, advocate for patient concerns, and dismantle implicit bias within clinical practice. Increasing representation across medical specialties—particularly in neurology, pulmonology, and rheumatology—is essential to ensuring that Black patients receive equitable, compassionate, and accurate care for complex, emerging conditions like long COVID.